Viking Global Investors’s Roivant Sciences ROIV Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$184M	Buy	6,652,448 +209,257	+3%	+$5.38M	0.52%	52
2025 Q4	$140M	Sell	6,443,191 -17,151,640	-73%	-$338M	0.37%	62
2025 Q3	$357M	Sell	23,594,831 -10,642,948	-31%	-$132M	0.93%	45
2025 Q2	$386M	Sell	34,237,779 -11,775,973	-26%	-$128M	1.12%	35
2025 Q1	$464M	Sell	46,013,752 -1,796,208	-4%	-$19.4M	1.48%	27
2024 Q4	$566M	Sell	47,809,960 -6,289,106	-12%	-$74.4M	1.83%	20
2024 Q3	$624M	Sell	54,099,066 -15,056,780	-22%	-$171M	2.28%	17
2024 Q2	$731M	Sell	69,155,846 -213,115	-0.3%	-$2.34M	2.81%	12
2024 Q1	$731M	Hold	69,368,961	–	–	2.72%	10
2023 Q4	$779M	Sell	69,368,961 -4,065,340	-6%	-$39.6M	2.85%	11
2023 Q3	$858M	Sell	73,434,301 -1,804,399	-2%	-$20.4M	3.48%	11
2023 Q2	$758M	Sell	75,238,700 -13,000,000	-15%	-$116M	3.1%	7
2023 Q1	$651M	Hold	88,238,700	–	–	3.06%	13
2022 Q4	$705M	Hold	88,238,700	–	–	3.53%	7
2022 Q3	$284M	Hold	88,238,700	–	–	1.31%	29
2022 Q2	$359M	Hold	88,238,700	–	–	1.64%	25
2022 Q1	$436M	Hold	88,238,700	–	–	1.76%	18
2021 Q4	$889M	Buy	+88,238,700	New	+$734M	2.56%	9